Evidence map›Paper›PMID 33336080›Full record

ArticleWellcome open research2020

Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV - pilot study.

Faith W Kamau, Agnes Gwela, Andrew K Nyerere, Victor Riitho, James M Njunge, Moses M Ngari, Andrew J Prendergast, James A Berkley

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Wellcome open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Faith W KamauClinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.
Agnes GwelaClinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.
Andrew K NyerereDepartment of Medical Microbiology, Jomo Kenyatta University of Agriculture and Technology, Juja, Nairobi, 62000-00200, Kenya.
Victor RiithoBlizard Institute, Queen Mary University of London, London, London, E1 2AT, UK.
James M NjungeClinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.ORCID https://orcid.org/0000-0002-8524-9133
Moses M NgariClinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.ORCID https://orcid.org/0000-0001-7149-5491
Andrew J PrendergastBlizard Institute, Queen Mary University of London, London, London, E1 2AT, UK.
James A BerkleyClinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.ORCID https://orcid.org/0000-0002-1236-849X
Kenya Medical Research Institute · KEQueen Mary University of London · GBJomo Kenyatta University of Agriculture and Technology · KE

Funding

EPA EP-C-15-003Medical Research Council MR/M007367/1Medical Research Council MR/P022251/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntiretroviralBiomarkerCD4HIVMortality; AdultNeutrophilPrognostic

Identifiers

PMID33336080
PMCPMC7722532
OpenAlexW3012067890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.